Related Experiment Videos
Hyperbaric oxygen therapy for nonhealing vasculitic ulcers
S Efrati1, J Bergan, G Fishlev
1The Institute of Hyperbaric Medicine and Wound Care Clinic, Assaf Harofeh Medical Center, Zerifin, Israel. efratishai@013.net
Clinical and Experimental Dermatology
|August 2, 2006
Summary
Hyperbaric oxygen therapy (HBO) significantly improved healing in patients with severe vasculitis-induced ulcers. This safe and effective treatment showed an 80% complete healing rate with no reported side-effects.
Area of Science:
- Vascular inflammation and tissue oxygenation research.
- Dermatology and wound healing studies.
- Hyperbaric medicine applications.
Background:
- Nonhealing skin ulcers are a serious complication of vasculitis.
- Hyperbaric oxygen (HBO) therapy is used for ischemic ulcers and may benefit vascular inflammation.
- Vasculitis-induced ulcers often resist conventional treatments.
Purpose of the Study:
- To assess the efficacy of hyperbaric oxygen (HBO) therapy for nonhealing skin ulcers caused by vasculitis.
- To evaluate the impact of HBO on tissue oxygenation in vasculitic ulcers.
- To determine the safety profile of HBO in this patient population.
Main Methods:
- 35 adult patients with severe, nonhealing vasculitis-induced ulcers were enrolled.
- Baseline ulcer tissue oxygenation was measured at various oxygen pressures (room air, 1 ATA, 2 ATA).
- Patients received a 4-week treatment of 100% oxygen at 2 ATA, five times weekly.
Main Results:
- Hyperbaric oxygen therapy significantly increased ulcer tissue oxygenation.
- 80% of patients achieved complete ulcer healing after 4 weeks of HBO.
- No adverse side-effects related to HBO therapy were observed in any patient.
Conclusions:
- Hyperbaric oxygen therapy is a safe and effective treatment option for vasculitis patients with nonhealing skin ulcers.
- Further research is warranted to explore HBO's role as a primary therapy for these ulcers.
- HBO therapy demonstrates significant potential in managing refractory vasculitic ulcers.